首页> 美国卫生研究院文献>PLoS Clinical Trials >Fo Shou San, an Ancient Chinese Herbal Decoction, Protects Endothelial Function through Increasing Endothelial Nitric Oxide Synthase Activity
【2h】

Fo Shou San, an Ancient Chinese Herbal Decoction, Protects Endothelial Function through Increasing Endothelial Nitric Oxide Synthase Activity

机译:佛手散,一种古老的中药汤,可通过增加内皮一氧化氮合酶的活性来保护内皮功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fo Shou San (FSS) is an ancient herbal decoction comprised of Chuanxiong Rhizoma (CR; Chuanxiong) and Angelicae Sinensis Radix (ASR; Danggui) in a ratio of 2∶3. Previous studies indicate that FSS promotes blood circulation and dissipates blood stasis, thus which is being used widely to treat vascular diseases. Here, we aim to determine the cellular mechanism for the vascular benefit of FSS. The treatment of FSS reversed homocysteine-induced impairment of acetylcholine (ACh)-evoked endothelium-dependent relaxation in aortic rings, isolated from rats. Like radical oxygen species (ROS) scavenger tempol, FSS attenuated homocysteine-stimulated ROS generation in cultured human umbilical vein endothelial cells (HUVECs), and it also stimulated the production of nitric oxide (NO) as measured by fluorescence dye and biochemical assay. In addition, the phosphorylation levels of both Akt kinase and endothelial NO synthases (eNOS) were markedly increased by FSS treatment, which was abolished by an Akt inhibitor triciribine. Likewise, triciribine reversed FSS-induced NO production in HUVECs. Finally, FSS elevated intracellular Ca2+ levels in HUVECs, and the Ca2+ chelator BAPTA-AM inhibited the FSS-stimulated eNOS phosphorylation. The present results show that this ancient herbal decoction benefits endothelial function through increased activity of Akt kinase and eNOS; this effect is causally via a rise of intracellular Ca2+ and a reduction of ROS.
机译:佛手散(FSS)是一种古老的草药汤,由川xi(CR;川xi)和当归(当归)(ASR;当归)组成,比例为2∶3。先前的研究表明,FSS促进血液循环并消散血瘀,因此被广泛用于治疗血管疾病。在这里,我们旨在确定FSS的血管益处的细胞机制。 FSS的治疗可逆转高半胱氨酸诱导的大鼠主动脉环中乙酰胆碱(ACh)引起的内皮依赖性舒张性损伤。像自由基氧(ROS)清除剂tempol一样,FSS减弱了培养的人脐静脉内皮细胞(HUVEC)中高半胱氨酸刺激的ROS生成,并且还通过荧光染料和生化测定刺激了一氧化氮(NO)的产生。此外,FSS处理显着提高了Akt激酶和内皮一氧化氮合酶(eNOS)的磷酸化水平,而Akt抑制剂曲西立滨则取消了该磷酸化水平。同样,曲西立滨逆转了FSS诱导的HUVEC中NO的产生。最后,FSS升高了HUVECs细胞内Ca 2 + 的水平,而Ca 2 + 螯合剂BAPTA-AM抑制了FSS刺激的eNOS磷酸化。目前的结果表明,这种古老的草药汤通过增加Akt激酶和eNOS的活性而有益于内皮功能。这种作用是由于细胞内Ca 2 + 的升高和ROS的降低引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号